CSI Market
Sign In | Register

Fate Therapeutics Inc (FATE) Annual Balance Sheets

Annual · GAAP · USD millions
Access FATE quarterly Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Fate Therapeutics Inc balances growth, leverage, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent46.63
Short-term Investments, Total157.03
Cash & Short-term Investments203.00
Accounts receivable0.92
Other Current Assets0.00
Prepaid Expense And Other Assets Current4.13
Total Current Assets208.70
Equipment/Property/Plant Net56.93
Long-term investments1.47
Other Assets, Noncurrent53.31
Short Term Investments And Related Maturity Receivables-
Total Assets318.94
Liabilities
Accounts Payable, Current AC2.66
Accrued Liabilities, Current AC20.02
Other Liabilities, Current13.39
Total Current Liabilities36.07
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
C I R M Award Liability Current8.45
Contract With Customer Liability Current0.38
Contract With Customer Liability Noncurrent-
C I R M Award Liability Noncurrent2.11
Total Liabilities36.07
Stockholders' Equity
Common Stock Value0.12
Additional Paid In Capital Common Stock1,741.26
Retained Earnings / Accumulated Deficit-1,534.31
Other Equity0.12
Common Stockholder's Equity207.18
Preferred Stockholder's Equity0.00
Total Stockholder's Equity207.18
Liabilities & Stockholder's Equity318.94
4 historic quarters locked

Sign in to unlock the full Fate Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Fate Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: fate-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-073699

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License